
Fudan University Shanghai Cancer Center
Oncology · National specialty reputationNo. 3
Pathology · National specialty reputationNo. 2
The Fudan classification of triple-negative breast cancer
A world first.
In 2019, the team led by Shao Zhimin and Jiang Yizhou introduced the Fudan classification, identifying four molecular subtypes of triple-negative breast cancer. The findings were published in Cancer Cell.
The immunohistochemical classification method entered the Chinese Anti-Cancer Association's Breast Cancer Diagnosis and Treatment Guidelines and Standards in 2021, bringing research into clinical testing.
Fudan classification · Original research and guideline adoptionThe team behind precision breast cancer subtyping
Shao Zhimin · Chief physician
Triple-negative and recurrent or metastatic breast cancer; assessment of surgical and comprehensive treatment options.



